M34101-040: An International, Non-comparative, Open-Label Study Of PS-341 Administered to Patients with Multiple Myeloma Who Experienced Relasped Or Progressive Disease After Recieving at Least Four Previous Treatment Regimens...

Project Details

Short titleM34101-040: An International, Non-comparative, Open-Label Study Of PS-341 Administered to Patients with Multiple Myeloma Who Experienced Relasped Or Progressive Disease After Recieving at Least Four Previous Treatment Regimens...
StatusFinished
Effective start/end date3/02/0331/03/06

Funding

  • MILLENNIUM PHARMACEUTICALS INC